CL
NBIX icon

Choreo LLC’s Neurocrine Biosciences NBIX Stock Holding History

Choreo LLC’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$606K Buy
3,593
+11
+0.3% +$1.63K 0.01% 886
2026
Q1 		$472K Sell
3,582
-88
-2% -$11.7K 0.01% 974
2025
Q4 		$517K Sell
3,670
-326
-8% -$47.2K 0.01% 908
2025
Q3 		$561K Sell
3,996
-6
-0.1% -$813 0.01% 871
2025
Q2 		$503K Buy
4,002
+1,298
+48% +$149K 0.01% 890
2025
Q1 		$299K Sell
2,704
-1,061
-28% -$134K ﹤0.01% 1089
2024
Q4 		$516K Buy
3,765
+1,156
+44% +$143K 0.01% 890
2024
Q3 		$298K Buy
2,609
+868
+50% +$119K ﹤0.01% 1207
2024
Q2 		$244K Buy
+1,741
New +$239K ﹤0.01% 1216

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Choreo LLC's NBIX Position: Q2 2026 in Review

Choreo LLC increased its Neurocrine Biosciences (NBIX) stake by 0.31% in Q2 2026, buying an estimated $1.63K and bringing the position to 3,593 shares worth $606K. The position accounts for 0.01% of the portfolio, ranked #886.

Choreo LLC first reported a position in NBIX in Q2 2024 and has held it in 9 quarters since. 777 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Choreo LLC held 3,593 shares of Neurocrine Biosciences worth $606K as of Q2 2026.
  • Choreo LLC bought 11 Neurocrine Biosciences shares in Q2 2026, an estimated $1.63K.
  • Neurocrine Biosciences made up 0.01% of Choreo LLC's portfolio in Q2 2026, its #886 holding.
  • Choreo LLC first reported a position in Neurocrine Biosciences in Q2 2024 and has held it in 9 quarters since.
  • 777 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.